198 related articles for article (PubMed ID: 33099421)
1. Systemic Amyloidosis due to Low-Grade Lymphoma.
Wechalekar AD; Chakraborty R; Lentzsch S
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1027-1039. PubMed ID: 33099421
[TBL] [Abstract][Full Text] [Related]
2. AL amyloidosis with a localized B cell neoplasia.
Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
[TBL] [Abstract][Full Text] [Related]
3. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases.
Bianchi G; Kumar S
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1009-1026. PubMed ID: 33099420
[TBL] [Abstract][Full Text] [Related]
4. New developments in diagnosis, risk assessment and management in systemic amyloidosis.
Vaxman I; Dispenzieri A; Muchtar E; Gertz M
Blood Rev; 2020 Mar; 40():100636. PubMed ID: 31706583
[TBL] [Abstract][Full Text] [Related]
5. Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?
Zhang C; Huang X; Li J
Blood Rev; 2017 Jul; 31(4):261-270. PubMed ID: 28336182
[TBL] [Abstract][Full Text] [Related]
6. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
Jalali S; Ansell SM
Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.
Wang Y; Xu L; Liu Y; Hu Y; Shi Q; Jin L; Yang L; Wang P; Zhang K; Huang X; Ge Q; Lu J
Int J Hematol; 2021 Feb; 113(2):231-242. PubMed ID: 33040275
[TBL] [Abstract][Full Text] [Related]
8. The Process of Amyloid Formation due to Monoclonal Immunoglobulins.
Morgan GJ; Wall JS
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1041-1054. PubMed ID: 33099422
[TBL] [Abstract][Full Text] [Related]
9. Endomyocardial biopsy with co-localization of a lymphoplasmacytic lymphoma and AL amyloidosis.
Leguit RJ; Vink A; de Jonge N; Minnema MC; Oerlemans MIF
Cardiovasc Pathol; 2021; 53():107348. PubMed ID: 34038803
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of systemic light chain AL amyloidosis.
Bhutani D; Lentzsch S
Pharmacol Ther; 2020 Oct; 214():107612. PubMed ID: 32562825
[TBL] [Abstract][Full Text] [Related]
11. Systemic AL amyloidosis associated with Waldenström macroglobulinemia: an unusual presenting complication.
Thakral B; Kanagal-Shamanna R
Blood; 2016 Jan; 127(1):168. PubMed ID: 27127826
[No Abstract] [Full Text] [Related]
12. Diagnostic challenges of amyloidosis in Waldenström macroglobulinemia.
Palladini G; Merlini G
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):244-6. PubMed ID: 23474147
[TBL] [Abstract][Full Text] [Related]
13. Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.
Oishi N; Inoue T; Odate T; Mochizuki K; Ohashi K; Kirito K; Kondo T
Pathol Int; 2020 Jul; 70(7):458-462. PubMed ID: 32323419
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
Andrei M; Wang JC
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
[TBL] [Abstract][Full Text] [Related]
15. Light Chain Amyloidosis (AL) Associated With B Cell Lymphoma a Single Center Experience.
la Torre A; Reece D; Crump M; Atenafu EG; Chen C; Prica A; Kukreti V
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e946-e959. PubMed ID: 34384733
[TBL] [Abstract][Full Text] [Related]
16. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
Gnemmi V; Leleu X; Provot F; Moulonguet F; Buob D
Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
[TBL] [Abstract][Full Text] [Related]
17. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.
Klimtchuk ES; Prokaeva TB; Spencer BH; Gursky O; Connors LH
Amyloid; 2017 Jun; 24(2):115-122. PubMed ID: 28632419
[TBL] [Abstract][Full Text] [Related]
18. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features of lymphoplasmacytic lymphoma].
Liu EB; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):308-12. PubMed ID: 20654153
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis.
Cuenca I; Alameda D; Sanchez-Vega B; Gomez-Sanchez D; Alignani D; Lasa M; Onecha E; Lecumberri R; Prosper F; Ocio EM; González ME; García de Coca A; De La Rubia J; Gironella M; Palomera L; Oriol A; Casanova M; Cabañas V; Taboada F; Pérez-Montaña A; De Arriba F; Puig N; Carreño-Tarragona G; Barrio S; Enrique de la Puerta J; Ramirez-Payer A; Krsnik I; Bargay JJ; Lahuerta JJ; Mateos MV; San-Miguel JF; Paiva B; Martinez-Lopez J
Leukemia; 2021 Jan; 35(1):245-249. PubMed ID: 32203144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
